|
⚲
|
| Keyboard |
| SAB Biotherapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001833214 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001833214] | |
| 10-Q | [0001833214] | |
| 3 | [0001833214] | |
| 4 | [0001833214] | |
| 5 | [0001833214] | |
| 8-K | [0001833214] | |
| D | [0001833214] | |
| SC 13D | [0001833214] | |
| SC 13G | [0001833214] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Kropotova Alexandra | |
| to Lucy | |
| Sullivan Eddie Joe | |
| Reich Samuel J | |
| Bausch Christoph Lawrence | |
| Zaccardelli David | |
| Jain Rita | |
| Ellias Helen K | |
| Link David | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2026-03-24 | Tax withheld | 988 | ||
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2026-02-03 | Grant | 4,800,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2026-02-03 | Grant | 1,800,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2026-02-03 | Grant | 2,400,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2026-02-03 | Grant | 3,000,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2026-02-03 | Grant | 2,400,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2026-01-05 | Grant | 240,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2026-01-05 | Grant | 240,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2025-12-11 | Tax withheld | 988 | ||
|
SAB Biotherapeutics Inc SABS
Series B Convertible Preferred Stock · derivative
|
2025-09-29 | Option exercise | 17,400 | ||
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2025-09-29 | Option exercise | 1,740,000 | $1.75 | 3,045,000 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2025-09-29 | Option exercise | 1,740,000 | $1.75 | 3,045,000 |
|
SAB Biotherapeutics Inc SABS
Series B Convertible Preferred Stock · derivative
|
2025-09-29 | Option exercise | 17,400 | ||
|
SAB Biotherapeutics Inc SABS
Warrants (right to buy) · derivative
|
2025-07-22 | Grant | 114,250 | ||
| showing 20 of 200 most recent transactions | |||||